Lee Frank D.
CIK 0001814686
President and CEODirector
Filings
18
Latest May 26, 2026
Issuers covered
4
Showing
18 of 18
Page 1
Track record
2 of 4 open-market trades scored (50% price coverage) - 2 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 100% | +7.5% | +7.5% | +9.2% | +5.8% |
| 90 days | 2 | 100% | +30.9% | +30.9% | +42.4% | +19.3% |
| 180 days | 2 | 100% | +66.3% | +66.3% | +112.4% | +20.1% |
| 365 days | 1 | 100% | +101.9% | +101.9% | +101.9% | +101.9% |
Issuers
Companies where Lee Frank D. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| PCRX | Pacira Biosciences, Inc. | 7 | Feb 13, 2026 |
| BHC | Bausch Health Companies Inc. | 5 | May 26, 2026 |
| BOLT | Bolt Biotherapeutics, Inc. | 4 | Jun 14, 2024 |
| FMTX | Forma Therapeutics Holdings, Inc. | 2 | Mar 2, 2022 |
All filings
18 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|